Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 7

1.

Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents.

Foissac F, Blanche S, Dollfus C, Hirt D, Firtion G, Laurent C, Treluyer JM, Urien S.

Br J Clin Pharmacol. 2011 Dec;72(6):940-7. doi: 10.1111/j.1365-2125.2011.04035.x.

2.

Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.

Le Tiec C, Barrail A, Goujard C, Taburet AM.

Clin Pharmacokinet. 2005;44(10):1035-50. Review.

PMID:
16176117
3.

[Efficacy of atazanavir in treatment-naive patients].

Moreno S, Hernández B, Dronda F.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:9-13. doi: 10.1016/S0213-005X(08)76614-X. Review. Spanish.

PMID:
20116611
4.

[Clinical utility of atazanavir].

Ribera Pascuet E, Curran A.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:55-67. doi: 10.1016/S0213-005X(08)76622-9. Review. Spanish.

PMID:
20116619
5.

A systematic review of the use of atazanavir in women infected with HIV-1.

Johnson M, Walmsley S, Haberl A.

Antivir Ther. 2014;19(3):293-307. doi: 10.3851/IMP2742. Epub 2014 Jan 31. Review.

PMID:
24480797
6.

[Pharmacology, pharmacokinetic features and interactions of atazanavir].

López-Cortés LF.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:2-8. doi: 10.1016/S0213-005X(08)76613-8. Review. Spanish.

PMID:
20116610
7.

Clinical pharmacokinetics of antiretroviral drugs in older persons.

Schoen JC, Erlandson KM, Anderson PL.

Expert Opin Drug Metab Toxicol. 2013 May;9(5):573-88. doi: 10.1517/17425255.2013.781153. Epub 2013 Mar 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk